Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02880215 · ClinicalTrials.gov registry record · NA

Development of Attention Bias Modification for Depression

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
145
Enrollment target

NCT02880215 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 145 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02880215, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
145 participants
Enrollment target

Study Summary

Although negatively biased attention has a central theoretical and empirical role in the maintenance of depression, there are few behavioral treatments that successfully target and improve this deficit. The current proposal builds upon prior work and aims to further develop an attention bias modification intervention. The investigators propose to develop a highly specific intervention that directly targets negative attention bias and the neurobiology that supports it, using cutting-edge cognitive neuroscience to inform treatment development and improve quality of life of patients whose psychopathology is maintained by negative attention bias.

Interventions

  • BEHAVIORAL Attention Bias Modification
  • BEHAVIORAL Cognitive Control Training

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2017-09-01
Est. Completion 2019-09-26
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT02880215

The ClinicalTrials.gov registry entry for NCT02880215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Attention Bias Modification is the first listed.

NCT02880215 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02880215 about?

NCT02880215 is a clinical study titled "Development of Attention Bias Modification for Depression". Although negatively biased attention has a central theoretical and empirical role in the maintenance of depression, there are few behavioral treatments that successfully target and improve this deficit. The current proposal builds upon prior work and aims to further develop an attention bias modific...

What is the current status of trial NCT02880215?

This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2017-09-01. Estimated completion is 2019-09-26.

What interventions are being tested in trial NCT02880215?

The interventions under investigation include: Attention Bias Modification (BEHAVIORAL), Cognitive Control Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02880215?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.